X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE STERLING BIOTECH SUVEN LIFE/
STERLING BIOTECH
 
P/E (TTM) x 13.9 -0.7 - View Chart
P/BV x 3.3 0.0 11,753.8% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 SUVEN LIFE   STERLING BIOTECH
EQUITY SHARE DATA
    SUVEN LIFE
Mar-17
STERLING BIOTECH
Dec-13
SUVEN LIFE/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs22911 2,176.2%   
Low Rs1513 4,444.1%   
Sales per share (Unadj.) Rs42.726.8 159.3%  
Earnings per share (Unadj.) Rs6.9-15.0 -45.8%  
Cash flow per share (Unadj.) Rs8.5-5.5 -156.2%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs52.454.9 95.5%  
Shares outstanding (eoy) m127.28267.87 47.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.40.3 1,714.3%   
Avg P/E ratio x27.7-0.5 -5,962.9%  
P/CF ratio (eoy) x22.2-1.3 -1,748.5%  
Price / Book Value ratio x3.60.1 2,860.1%  
Dividend payout %14.60-   
Avg Mkt Cap Rs m24,1581,862 1,297.6%   
No. of employees `0001.01.4 75.0%   
Total wages/salary Rs m522547 95.4%   
Avg. sales/employee Rs Th5,349.75,303.3 100.9%   
Avg. wages/employee Rs Th513.5403.8 127.2%   
Avg. net profit/employee Rs Th858.1-2,959.0 -29.0%   
INCOME DATA
Net Sales Rs m5,4357,181 75.7%  
Other income Rs m21143 495.1%   
Total revenues Rs m5,6467,223 78.2%   
Gross profit Rs m1,291947 136.3%  
Depreciation Rs m2142,543 8.4%   
Interest Rs m574,377 1.3%   
Profit before tax Rs m1,231-5,931 -20.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m359-1,924 -18.6%   
Profit after tax Rs m872-4,007 -21.8%  
Gross profit margin %23.713.2 180.1%  
Effective tax rate %29.232.4 89.9%   
Net profit margin %16.0-55.8 -28.7%  
BALANCE SHEET DATA
Current assets Rs m4,91714,335 34.3%   
Current liabilities Rs m1,18649,809 2.4%   
Net working cap to sales %68.6-494.0 -13.9%  
Current ratio x4.10.3 1,440.5%  
Inventory Days Days62403 15.4%  
Debtors Days Days31171 18.0%  
Net fixed assets Rs m3,15455,432 5.7%   
Share capital Rs m127268 47.5%   
"Free" reserves Rs m6,54313,935 47.0%   
Net worth Rs m6,67014,701 45.4%   
Long term debt Rs m2599,478 2.7%   
Total assets Rs m8,15773,988 11.0%  
Interest coverage x22.7-0.4 -6,385.8%   
Debt to equity ratio x00.6 6.0%  
Sales to assets ratio x0.70.1 686.6%   
Return on assets %11.40.5 2,272.9%  
Return on equity %13.1-27.3 -48.0%  
Return on capital %18.6-6.4 -289.2%  
Exports to sales %025.9 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m4,9961,860 268.6%   
Fx outflow Rs m95925 3,853.0%   
Net fx Rs m4,0371,835 220.0%   
CASH FLOW
From Operations Rs m1,0881,719 63.3%  
From Investments Rs m-3,107-3,148 98.7%  
From Financial Activity Rs m-3001,426 -21.1%  
Net Cashflow Rs m-2,319-3 68,194.1%  

Share Holding

Indian Promoters % 63.4 33.9 187.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 9.9 -  
ADR/GDR % 0.0 16.9 -  
Free float % 36.5 39.3 92.9%  
Shareholders   37,287 21,482 173.6%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   UNICHEM LAB  SUN PHARMA  PFIZER  GLENMARK PHARMA  AUROBINDO PHARMA  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day Flat; Auto Stocks Top Gainers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a positive note.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


May 22, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS